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Activation of Cardiac Gene Expression
by Myocardin, a Transcriptional Cofactor
for Serum Response Factor
through combinatorial associations with accessory
factors.
SRF is expressed in a wide range of cell types and was
first identified by its ability to confer serum inducibility to
the c-fos promoter (Norman et al., 1988). Growth factor
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CArG boxes are also required for expression of many
skeletal and cardiac muscle genes and every smoothSerum response factor (SRF) regulates transcription
muscle-specific gene analyzed to date (reviewed inof numerous muscle and growth factor-inducible
Reecy et al., 1998). The requirement of SRF for expres-genes. Because SRF is not muscle specific, it has been
sion of growth factor-inducible and muscle-specificpostulated to activate muscle genes by recruiting
genes is paradoxical since growth factor signaling re-myogenic accessory factors. Using a bioinformatics-
presses muscle gene expression. The mutually exclu-based screen for unknown cardiac-specific genes, we
sive expression patterns of these two sets of SRF-regu-identified a novel and highly potent transcription fac-
lated genes has led to the suggestion that SRFtor, named myocardin, that is expressed in cardiac
cooperates with myogenic accessory factors to selec-and smooth muscle cells. Myocardin belongs to the
tively activate muscle target genes. Indeed, SRF hasSAP domain family of nuclear proteins and activates
been shown to cooperate with the cardiac-restrictedcardiac muscle promoters by associating with SRF.
zinc finger transcription factor GATA4 (Belaguli et al.,Expression of a dominant negative mutant of myocar-
2000; Morin et al., 2001) and the homeodomain proteindin in Xenopus embryos interferes with myocardial
Nkx2.5 (Chen and Schwartz, 1996), but these factorscell differentiation. Myocardin is the founding member
are relatively weak activators and they do not form aof a class of muscle transcription factors and provides
stable ternary complex with SRF on DNA.a mechanism whereby SRF can convey myogenic ac-
Here, we describe a novel transcriptional cofactor oftivity to cardiac muscle genes.
SRF, called myocardin, discovered using a bioinformat-
ics approach to identify unknown cardiac-specific
Introduction genes. Myocardin belongs to the SAP (SAF-A/B, Acinus,
PIAS) domain family of nuclear proteins, which regulate
The mechanisms that control skeletal muscle gene ex- diverse aspects of chromatin remodeling and transcrip-
pression have been defined in considerable detail (re- tion. Myocardin is highly expressed in embryonic car-
viewed in Hauschka, 1994), but relatively little is known diac and smooth muscle lineages before becoming re-
of the mechanisms that regulate cardiac and smooth stricted to the myocardium after birth. Myocardin is an
muscle genes. A common feature of many muscle genes extraordinarily potent transcriptional activator that acti-
is their dependence on a cis-acting sequence known as vates CArG box-dependent cardiac promoters by form-
a CArG box (CC(A/T)6GG), which serves as the binding ing a ternary complex with SRF. Through expression in
site for serum response factor (SRF) (reviewed in Shore Xenopus embryos of a dominant negative myocardin
and Sharrocks, 1995). SRF belongs to the MADS (MCM1, mutant that can associate with SRF but cannot activate
Agamous, Deficiens, SRF) box family of transcription transcription, we show that myocardin is required for
factors, which includes MEF2, a muscle-enriched tran- myocardial cell differentiation in vivo. The association
scription factor required for differentiation of skeletal, of SRF with myocardin provides a mechanism whereby
cardiac, and smooth muscle cell types (Black and Olson, SRF can convey myogenic activity to cardiac target
1998). The MADS domain mediates homodimerization genes.
and DNA binding, and recruits a variety of transcriptional
cofactors that influence DNA binding affinity, transcrip- Results
tional activity, and target gene specificity (reviewed in
Treisman, 1994). A hallmark of MADS domain proteins Cloning of Myocardin by a Bioinformatics-Based
is their ability to activate different sets of genes by inter- Screen In Silico
preting various intracellular signals and cell identities In an effort to identify unknown cardiac-specific genes,
we searched expressed sequence tag (EST) databases
for novel sequences found only in cardiac cDNA librar-4 Correspondence: eolson@hamon.swmed.edu
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Figure 1. Deduced Amino Acid Sequence
and Homology of Myocardin with other SAP
Domain Proteins
(A) Deduced amino acid sequence of mouse
myocardin (accession number AF384055).
(B) Homology of myocardin with SAP domain
proteins. AC005358 is a human genomic se-
quence that likely represents the ortholog of
mouse myocardin. AB037859 is a human EST
sequence for a myocardin-related gene.
AE003475 and AE003683 are Drosophila ge-
nomic sequences. The two predicted  heli-
ces of the SAP domain are shown at the top.
a, acidic; b, basic; h, hydrophobic.
ies. Sequences that did not correspond to known genes attachment regions (SARs/MARs), Acinus, a caspase-3-
activated protein required for apoptotic chromatin con-were then used as probes for in situ hybridization to
E9.5 mouse embryos and for Northern blot analysis of densation, and PIAS, an inhibitor of STAT-mediated gene
activation. The SAP domain is a 35 amino acid motifadult mouse tissues, in order to further confirm their
possible cardiac-specific expression. One of the cDNAs containing two predicted amphipathic helices separated
by an intervening region with an invariant glycine resi-identified in this screen corresponded to a 3 untrans-
lated region, which we used to isolate full-length cDNAs. due. The two helices, which contain several highly con-
served positively charged residues, have been predictedThe extended cDNA sequence encoded a novel protein
of 807 amino acids (Figure 1A), which we named myocar- to resemble helices-1 and -2 of the homeodomain (Kipp
et al., 2000). However, SAP domain proteins do not con-din because of its specific expression in the adult myo-
cardium and its essential role in myocardial gene ex- tain a third helix as is found in homeodomain proteins.
Myocardin does not show homology to other knownpression in vivo.
Myocardin contains a SAP domain (Figure 1B), found proteins outside of the SAP domain. However, we identi-
fied additional mouse, human, and Drosophila se-in a variety of proteins that influence nuclear architecture
and transcription (reviewed in Aravind and Koonin, quences encoding proteins with homology to the SAP
and basic domains of myocardin (Figure 1B).2000). Other notable features of myocardin include a
basic region, an extended amphipathic  helix resem-
bling a leucine zipper, and a stretch of glutamine (Q)
residues (Figure 1A). Myocardin Is Highly Expressed in Developing
Cardiac and Smooth MuscleThe SAP domain is named for the nuclear scaffold
attachment factors A and B (SAF-A and -B), which recog- Northern blot analysis of adult mouse tissues revealed
multiple myocardin transcripts specifically in adult heart.nize chromosomal regions known as scaffold or matrix
Myocardin, a Transcriptional Cofactor for SRF
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Figure 2. Expression of Myocardin Transcripts in Embryonic and Adult Mouse Tissues
(A) An adult mouse tissue Northern blot (Clontech) probed with a myocardin cDNA fragment.
(B) Myocardin transcripts were detected by whole-mount (a and c) or section (b and d–i) in situ hybridization to mouse embryos. (a) E7.75.
Myocardin expression is localized to the cardiac crescent (cc). (b) E8.0. Transverse section shows myocardin expression specifically in the
heart tube (ht) beneath the head folds (hf). (c) E8.0. Myocardin expression is detected throughout the linear heart tube. (d) E10.5. Saggital
section shows myocardin expression localized to the heart. A subset of head mesenchyme cells also express myocardin at a low level. (e)
E11.5. Transverse section shows myocardin expression in atrial (a) and ventricular (v) chambers. (f–h) E13.5. (f) Sagittal section shows myocardin
expression in atrial and ventricular chambers and in adjacent pulmonary smooth muscles of the branches of the segmental bronchus of the
lung (l). (g) Transverse sections through the outflow tract vasculature at E13.5 show myocardin expression in the smooth muscle cell layers
of the outflow tract (ot), trachea (t), and aortic arch arteries (aa). (h) Myocardin expression in smooth muscle of the stomach (s) and gut (g).
(i) E15.5. Transverse section shows myocardin expression in the heart and esophagus (e).
There was no detectable expression of myocardin in fusing it to the DNA binding domain of yeast GAL4. As
shown in Figure 3B, myocardin fused to the GAL4 DNAany other adult tissue examined (Figure 2A).
In situ hybridization to staged mouse embryos binding domain potently activated a GAL4-dependent
reporter in transfected COS cells. Residues 50–537 orshowed that myocardin transcripts were first detected in
the cardiac crescent at E7.75 (Figure 2B, a), concomitant portions of this region showed no transcriptional activity
in this assay, whereas the region from residues 541–807with expression of the homeobox gene Nkx2.5, the earli-
est known marker for cardiogenic specification (Lints et was approximately 60-fold more active than the full-
length protein. This suggests that the amino-terminalal., 1993). Thereafter, myocardin transcripts were de-
tected specifically in the linear heart tube at E8.0 (Figure portion of myocardin may mask the activation domain
or mediate protein-protein or protein-DNA interactions2B, b and c) and throughout the developing atrial and
ventricular chambers until birth (Figure 2B, d–f and i). that compete for activation through the GAL4 DNA bind-
ing site. Further carboxy-terminal deletions resulted inMyocardin is also expressed in a subset of embryonic
vascular and visceral smooth muscle cells. At E13.5, diminished transcriptional activity, suggesting that the
activation domain is distributed over a relatively ex-myocardin expression was evident within smooth mus-
cle cells lining the walls of the esophagus and aortic tended region.
arch arteries, as well as the pulmonary outflow tract
(Figure 2B, f and g). Expression in these smooth muscle Myocardin Activates Transcription through
cell types was still apparent, but was diminished, by SRF Binding Sites
E15.5 (data not shown). Myocardin expression was also To identify potential target genes for myocardin, we
detected in smooth muscle cells within the lung and gut tested a series of cardiac muscle gene regulatory re-
(Figure 2B, f and h), as well as in head mesenchyme gions linked to a luciferase reporter for their respon-
(Figure 2B, d), which may serve as a source of smooth siveness to myocardin in transfected COS cells. Myocar-
muscle precursors. Myocardin was not expressed at din strongly transactivated the promoters for the SM22,
detectable levels in skeletal muscle. atrial natriuretic factor (ANF), myosin light chain (MLC)-
2V, and -MHC genes, as well as the enhancer for the
Nkx2.5 gene (Figure 4A). In contrast, myocardin failedMyocardin Is a Highly Potent Transactivator
As a first step toward determining the function of myo- to activate the HRT2 promoter or the dHAND enhancer,
which are active in subsets of cardiac muscle cells. Thecardin, we examined the subcellular distribution of the
protein in transfected COS cells. Myocardin protein was cytomegalovirus (CMV) or E1b promoters, which show
no tissue specificity, also were not activated by myocar-localized predominantly to the nucleus and showed a
punctate intranuclear staining pattern with exclusion din, indicating that myocardin does not act as a general
transcriptional activator.from nucleoli (Figure 3A).
Because myocardin was localized to the nucleus, we The SM22 promoter was the most responsive to myo-
cardin, being upregulated by several thousand-fold.tested whether it possessed transcriptional activity by
Cell
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Figure 3. Nuclear Localization and Transcriptional Activity of Myocardin
(A) Subcellular location of myocardin protein in transfected COS cells, detected by immunostaining.
(B) COS cells were transiently transfected with expression vectors encoding the indicated regions of myocardin fused to GAL4 (1–147) and
the pL8G5-luciferase reporter, which contains binding sites for the GAL4 DNA binding domain. Luciferase activity is expressed as fold-increase
above that with the GAL4 expression plasmid without a cDNA insert.
SM22 encodes a troponin-related protein expressed in myocardin, whereas SRF was only able to activate ex-
pression by 8-fold (Figure 4C). Together, these resultsdeveloping cardiac, smooth, and skeletal muscle cells
during early embryogenesis, before becoming restricted demonstrate that myocardin is a much more potent
transactivator than SRF, and that myocardin acts prefer-specifically to the smooth muscle lineage (Li et al., 1996).
Transcription of SM22 in cardiac and smooth muscle entially through multiple CArG boxes.
As shown in Figure 4D, myocardin was extremelycells in vivo is dependent on two CArG boxes in the
promoter, referred to as CArG-near (at 150/141) and sensitive to the level of SRF, such that at low concentra-
tions of SRF expression plasmid, myocardin and SRFCArG-far (at 273/264), that bind SRF (Li et al., 1997;
Kim et al., 1997). Although these sites are essential for synergistically activated SM22 transcription, whereas
at higher concentrations of SRF, transcriptional activa-SM22 transcription, SRF transactivates the SM22 pro-
moter only about 10-fold in nonmuscle cells, suggesting tion by myocardin was reduced. Inhibition of myocardin-
dependent transcription by excess SRF could be re-that an additional SRF cofactor may be required for full
activity of the SM22 promoter in muscle cells. lieved by increasing the amount of myocardin. We
conclude from these results that the ratio of SRF toTo investigate the potential requirement of the SM22
CArG boxes for responsiveness to myocardin, we tested myocardin is important for transcriptional activation by
myocardin, and that exceeding an optimal ratio withwhether mutations in either CArG box in the context
of the 1343 bp promoter impaired responsiveness to an excess of SRF results in attenuation of myocardin
activity.myocardin. Mutation of the distal CArG box (CArG-far)
reduced responsiveness to myocardin by 5-fold, but this
mutant promoter was still activated several hundred- Domain Mapping of Myocardin
To further define the mechanism for myocardin-depen-fold. In contrast, mutation of the proximal CArG box (CArG-
near) almost completely eliminated the ability to respond dent transcription, we analyzed the transcriptional activ-
ity of a series of amino- and carboxy-terminal deletionto myocardin, and mutation of both CArG boxes com-
pletely abolished activation by myocardin (Figure 4B). mutants (Figure 5A). Deletion of the first 66 residues
(mutant N66) did not impair transcriptional activity ofThe ANF promoter also contains two CArG boxes that
are required for transcriptional activity in cardiomyo- myocardin with either the SM22 or ANF promoters. In
contrast, further amino-terminal deletion to residue 140cytes (Hines et al., 1999). As with the SM22 promoter,
mutation of the distal CArG box severely reduced activa- (mutant N140), which eliminates the basic region, re-
sulted in a complete loss in transcriptional activity. Thetion by myocardin, and a promoter with both CArG boxes
mutated was unable to respond to myocardin (Figure loss in activity of this mutant appears to be due to dele-
tion of the basic region because an internal deletion4B). In contrast to the extreme sensitivity of the SM22
and ANF promoters to myocardin, the c-fos promoter, mutant (basic) lacking only the basic region was also
unable to activate transcription. All further N-terminalwhich contains a single essential CArG box (Gilman et
al., 1986), was not activated by myocardin (Figure 4A). deletions up to amino acid 615, as well as an internal
deletion of the Q-rich domain (mutant Q), also elimi-To determine whether the CArG box was sufficient to
confer transcriptional responsiveness to myocardin, we nated transcriptional activity (Figure 5A).
Deletion of residues 585–807 (mutant C585) or 381–tested whether myocardin could transactivate reporter
genes containing four tandem copies of SM22 CArG- 807 (C381) also abolished all transcriptional activity.
These results are consistent with the results of GAL4near or the c-fos SRE linked to the E1b promoter. These
reporters were transactivated several hundred-fold by fusions, which indicated the existence of a transcription
Myocardin, a Transcriptional Cofactor for SRF
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Figure 4. Activation of CArG Box-Dependent Promoters by Myocardin
(A) Activation of cardiac and smooth muscle reporter genes by myocardin in transfected COS cells. Values are expressed as the fold-increase
in luciferase activity in the presence of myocardin expression plasmid compared to the level of activity with reporter plasmid alone.
(B) Analysis of the effects of CArG box mutations on activation of the SM22 and ANF promoters by myocardin and SRF. Values are expressed
as luciferase activity of each construct compared to the wild-type construct, which was assigned a value of 100. Values in parentheses
indicate the fold-increase in activity in the presence of myocardin expression plasmid compared to the level of activity with reporter alone.
NT, not tested.
(C) COS cells were transiently transfected with a luciferase reporter linked to the E1b basal promoter and four tandem copies of either CArG-
near from the SM22 promoter (left) or the c-fos SRE (right) and expression vectors for myocardin and SRF.
(D) COS cells were transiently transfected with the SM22-luciferase reporter and the indicated amounts (in ng) of myocardin and SRF expression
plasmids. Results in (A), (B), and (C) are from representative experiments. Results in (D) are the average  standard error of three independent
experiments.
activation domain between residues 541 and the car- dependent promoters. The basic region also appears to
be required for nuclear localization since deletion of thisboxyl terminus. Interestingly, when coexpressed with
full-length myocardin, these carboxy-terminal deletion region resulted in relocalization of myocardin from the
nucleus to the cytoplasm (data not shown).mutants acted in a dominant negative manner and se-
verely impaired the ability of the wild-type protein to We examined the functional importance of the SAP
domain by introducing proline mutations into helix-1 oractivate the SM22 (Figure 5B) and ANF promoters (data
not shown). -2 (mutants PSF and PGH). These mutations had only
a modest effect on the ability of myocardin to transacti-To determine whether the transactivation domain con-
ferred specificity to myocardin, we fused the viral coacti- vate the SM22 promoter, but they abolished activation
of the ANF promoter. Similarly, deletion of the linkervator protein VP16 to the carboxy-terminal deletion mu-
tants that were transcriptionally inactive. As shown in region between the two helices of the SAP domain,
shown previously to be required for DNA binding byFigure 5A, myocardin-VP16 fusions containing residues
1–381 or 1–585 acted as potent activators of the SM22 SAF-A (Kipp et al., 2000), had little effect on SM22 activa-
tion, but eliminated ANF activation.and ANF promoters. Together, these results suggest
that the carboxyl terminus of myocardin functions as a
general transcription activation domain, and that the Myocardin Forms a Complex with SRF
To further determine the mechanism for CArG box-basic and Q-rich domains near the amino terminus are
required for directing the activation domain to CArG box- dependent transcriptional activation by myocardin, we
Cell
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Figure 5. Mapping Domains of Myocardin
Required for Activation of the SM22 and ANF
Promoters
(A) Deletion mapping of the domains of myo-
cardin required for activation of the SM22 and
ANF promoters. All myocardin deletions con-
tained a FLAG epitope at the amino terminus
and their expression was confirmed by West-
ern blot.
(B) Dominant negative effects of C-terminal
deletion mutants in transfection assays. Equiv-
alent amounts of expression plasmid for myo-
cardin and myocardin mutants were trans-
fected with the SM22-luciferase reporter
plasmid and luciferase activity was deter-
mined.
(C) The indicated mutations were introduced
into the SAP domain of myocardin and were
used to test for transactivation of the SM22-
luciferase and ANF-luciferase reporters. Val-
ues are expressed as luciferase activity of
each construct compared to the wild-type
construct, which was assigned a value of 100.
Results of representative experiments are
shown. Average values for assays varied by
less than 5% of the mean.
tested whether myocardin translated in vitro could bind supershifted by antibodies against SRF or FLAG-tagged
myocardin. The total amount of SRF DNA binding wasto the CArG boxes from the SM22 promoter. SRF bound
to both CArG boxes, but no binding of myocardin to comparable in the presence and absence of myocardin,
suggesting that association of SRF with myocardin doeseither CArG box was detectable in gel mobility shift
assays. However, myocardin in the presence of SRF not alter the affinity of SRF for the CArG box. Myocardin
and SRF also formed a ternary complex with the c-fosgave rise to a prominent ternary complex with the CArG
box sequence (Figure 6A). This ternary complex was and ANF CArG boxes, the intensity of which correlated
Myocardin, a Transcriptional Cofactor for SRF
857
Figure 6. Ternary Complex Formation between Myocardin and SRF
(A) Gel mobility shift assays were performed with a 32P-labeled oligonucleotide probe for SM22 CArG-near and in vitro translation products
of FLAG-tagged myocardin in the presence and absence of SRF. Antibodies against SRF and the FLAG-epitope were included, as indicated.
(B) Gel mobility shift assays were performed as in (A) with SRF and wild-type and mutant forms of FLAG-tagged myocardin.
(C) Gel mobility shift assays were performed as in (A) with an SRF deletion mutant (SRF 100–300) lacking the amino and carboxyl termini.
(D) Coimmunoprecipitation of myocardin and SRF from transiently transfected COS cells. Immunoprecipitates were separated by SDS-PAGE
and sequentially immunoblotted with anti-FLAG antibody (top panel). The same blot was then reprobed with anti-HA antibody to determine
the presence of HA-tagged SRF (bottom panel). One-twentieth of the cell extract was directly immunoblotted with anti-FLAG antibody to
detect the presence of FLAG-tagged myocardin (middle panel).
(E) Schematic diagrams of myocardin mutants showing the ability to form a ternary complex with SRF.
directly with the relative binding of SRF to the site (data interpretation that the amino terminus of myocardin con-
fers transcriptional specificity by mediating associationnot shown). The lack of obvious homology in the flanking
sequences of these different CArG boxes suggests that with SRF, whereas the carboxyl terminus activates tran-
scription.myocardin associates directly with SRF and does not
depend on specific DNA sequences for ternary complex To determine whether myocardin interacted with the
DNA binding or transcription activation domain of SRF,formation (see below).
The region of myocardin required for ternary complex we performed gel mobility shift assays with an SRF
deletion mutant encompassing the MADS domain butformation with SRF was determined using myocardin
deletion mutants. Deletion of the amino-terminal 140 lacking the amino and carboxyl termini. This SRF mutant
(SRF 100–300) bound the CArG box sequence andamino acids (N140) abolished association with SRF,
as did larger amino-terminal deletions (Figures 6B and formed a ternary complex with myocardin (Figure 6C).
Association of myocardin and SRF was also readily6D). In contrast, deletions from amino acid 381 to the
carboxyl terminus did not affect SRF interaction (mu- detectable in coimmunoprecipitation assays of epitope-
tagged proteins. Interaction was dependent on thetants C381 and C585). Deletion of the Q-rich domain
or the basic region also abolished ternary complex for- amino-terminal region of myocardin, as demonstrated
by the association of myocardin mutant C585, but notmation, whereas mutation of the SAP domain (PSF mu-
tant) did not. These findings are consistent with the N585, with SRF (Figures 6D and 6E). The core MADS
Cell
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domain of SRF (residues 133–266) was also necessary of muscle gene expression: (1) during embryogenesis,
and sufficient to mediate association with myocardin in myocardin is expressed in cardiac and a subset of
coimmunoprecipitation assays. smooth muscle cells, concomitant with the expression
Together, these results demonstrate that myocardin of SRF-dependent muscle genes. (2) Myocardin is an
interacts with SRF to form a stable ternary complex. extraordinarily potent transcriptional activator that en-
The direct correlation between the ability of myocardin hances transcriptional activation by SRF. (3) Transcrip-
mutants to activate SM22 and ANF transcription and to tional activation by myocardin is extremely sensitive to
interact with SRF supports the conclusion that myocar- the level of SRF. If SRF levels exceed a narrow range,
din activates transcription via its association with SRF. transcriptional activity of myocardin is diminished. (4)
Transcriptional activation by myocardin is mediated by
Inhibition of Cardiomyocyte Differentiation in the CArG box sequence. (5) Myocardin associates with
Xenopus Embryos by Dominant Negative Myocardin the CArG box sequence only in the presence of SRF,
To investigate the functions of myocardin in vivo, we and mutants of myocardin that cannot interact with SRF
analyzed the effects of the dominant negative myocardin cannot activate transcription. Conversely, mutants of
mutant C585 on cardiac gene expression in Xenopus myocardin that can associate with SRF, but which lack
embryos, which express at least two myocardin-like the transactivation domain, prevent CArG box-depen-
genes (D. Wang, L. Sutherland, and E. Olson, unpub- dent transcription by wild-type myocardin. (6) The latter
lished data). Single dorsal-vegetal blastomeres of 8-cell type of dominant negative myocardin mutant interferes
Xenopus embryos were injected with synthetic mRNA with cardiomyocyte differentiation in vivo.
encoding C585. Due to the fate map of the 8-cell Xeno-
pus embryo, injections targeted to the heart always re- Myocardin Is Required for Heart Development
sult in coexpression in the developing somites. Injected Myocardin expression is initiated in the cardiac crescent
embryos were assayed for expression of muscle mark- at the time of cardiogenic specification and is main-
ers by whole-mount in situ hybridization at the early tained throughout the atrial and ventricular chambers
tailbud stage. At this stage, the heart-forming region of the heart during later development. Myocardin is also
consists of two symmetrical domains of tissue located expressed in embryonic vascular smooth muscle cells
on either side of the ventral midline, allowing the unin- within the cardiac outflow tract and aortic arch arteries,
jected side of the embryo to serve as an internal control as well as in developing visceral smooth muscle cells
for the injected, experimental side. The distribution of of the respiratory, gastrointestinal, and genitourinary
mutant myocardin transcripts was visualized by coinjec- tracts. However, myocardin is not expressed in the coro-
tion of GFP mRNA. nary vasculature or the dorsal aorta, nor in skeletal muscle
The side of the embryo injected with C585 mRNA cells. Since CArG boxes have been shown to be required
showed a dramatic reduction in expression of tran- for expression of muscle genes in all muscle cell types,
scripts for cardiac -actin and -tropomyosin (Figures there must be myogenic SRF cofactors in addition to
7A and 7B), which are markers for cardiac and skeletal myocardin. Whether other myocardin-related factors
myocyte differentiation. The effects of dominant nega-
identified as EST or genomic sequences (Figure 1B) play
tive myocardin on cardiac differentiation were highly
this role remains to be determined.
specific, as demonstrated first by the normal overall
Our results demonstrate that a dominant negative my-appearance of the embryo and second by the wild-type
ocardin mutant that can associate with SRF, but cannotexpression of these markers in the somite myotomes
activate transcription, specifically interferes with cardio-which also received the C585 transcript. Expression
myocyte differentiation when expressed in the dorsal-of troponin I, a heart-specific differentiation marker, was
vegetal blastomere that gives rise to the cardiac lineagealso inhibited by C585 (data not shown). In addition,
in Xenopus. Intriguingly, dominant negative myocardinexpression of Nkx2.5 was severely reduced in C585-
did not inhibit skeletal muscle differentiation in the so-injected embryos. The overall morphology of the em-
mite myotomes, as assayed by expression of cardiacbryos expressing C585 was normal, indicating that the
-actin and -tropomyosin. These findings are consis-mutant did not affect general aspects of embryogenesis.
tent with the lack of myocardin expression in the skeletalWe attempted to rescue C585-injected embryos by
muscle lineage and suggest that other factors in skeletalinjection of wild-type myocardin mRNA. However, over-
muscle interfere with the dominant negative effects ofexpression of wild-type myocardin resulted in severe
the myocardin mutant. The precise role of myocardin inmorphologic abnormalities and embryonic lethality.
vascular development remains to be determined.Expression of the C585 mutant resulted in a dose-
The finding that dominant negative myocardin inhibitsdependent reduction in expression of cardiac markers,
the expression of multiple cardiac structural genes, assuch that approximately 90% of injected embryos exhib-
well as Nkx2.5, which is normally expressed prior toited a reduction or complete elimination of cardiac gene
cardiomyocyte differentiation, suggests that myocardinexpression on the injected side (Table 1). In contrast,
plays an essential early role in the cardiac develop-defects were observed in 5% or less of embryos injected
mental pathway. The effects of dominant negative myo-with the GFP marker alone. Together, these results dem-
cardin in vivo suggest that this mutant sequesters SRFonstrate that dominant negative myocardin can specifi-
and prevents endogenous myocardin from forming acally interfere with myocardial differentiation in vivo.
transcriptionally active complex. Accordingly, SRF is
highly expressed in the early heart (Croissant et al.,Discussion
1996). However, we cannot rule out the possibility that
myocardin may have other partners in vivo that accountMyocardin is a novel SRF cofactor with the following
properties that implicate it in SRF-dependent activation for the inhibition of cardiac differentiation by this mutant.
Myocardin, a Transcriptional Cofactor for SRF
859
Figure 7. Inhibition of Myocardial Gene Ex-
pression by Expression of Dominant Negative
Myocardin in Xenopus Embryos
Xenopus embryos at the 8-cell stage were
injected with mRNA encoding the C585 mu-
tant of myocardin and GFP or GFP alone (con-
trol) and were assayed for expression of (A)
cardiac -actin, (B) -tropomyosin, or (C)
Nkx2.5 at stage 28 by whole-mount in situ
hybridization. (A, e–h), (B, c–d), and (C) show
ventral views; other panels show lateral
views. The dotted line bisects the symmetri-
cal heart-forming region. Arrowheads show
the heart on the injected side, which displays
a reduced level of expression of cardiac
markers. cg, cement gland; h, heart; s, so-
mites.
Previous studies showed that dominant negative or by interference with CArG box-dependent cardiac
structural genes, or both.Nkx2.5 mutants were able to prevent cardiac develop-
ment in injected Xenopus embryos (Fu et al., 1998; Grow
and Krieg, 1998). Thus, because the dominant negative
Coregulation of Muscle Gene Expressionmyocardin mutant interferes with Nkx2.5 expression, its
by SRF and Myocardineffects could be mediated by downregulation of Nkx2.5
In contrast to the association of SRF with p62TCF, which
requires contact of TCF with a specific DNA sequence
flanking the CArG box (Shaw et al., 1989), myocardin
Table 1. Summary of Dominant Negative Myocardin Phenotypes and SRF can form a complex in the absence of DNA.
in Injected Xenopus Embryos Association with myocardin does not change the DNA
Reduced/ # Embryos binding activity of SRF, suggesting that the enhanced
mRNA Normal Eliminated Assayed transcriptional activity of SRF upon association with
myocardin is due to the recruitment of the potent tran--Cardiac Actin
scription activation domain of myocardin, rather than to
Control 39 (95%) 2 (5%) 41
an increase in DNA binding affinity of SRF. MyocardinC585 (200 pg) 8 (29%) 20 (71%) 28
interacts with the MADS domain region of SRF, whichC585 (500 pg) 2 (9%) 21 (91%) 23
is structurally similar to that of MEF2 (Santelli and Rich-
-Tropomyosin
mond, 2000). However, we have detected no interaction
Control 41 (95%) 2 (5%) 43 between myocardin and MEF2 (data not shown).
C585 (150 pg) 9 (27%) 25 (73%) 34 Myocardin appears to require a very precise level
C585 (300 pg) 7 (20%) 28 (80%) 35
of SRF for maximal transcriptional activity; elevation
Nkx2.5 of SRF above a narrow range results in suppression of
myocardin-dependent transcription. Since SRF is aControl 32 (97%) 1 (3%) 33
much weaker activator than myocardin and can associ-C585 (200 pg) 7 (33%) 14 (67%) 21
ate with myocardin in the absence of DNA binding, ex-Single dorsal-vegetal blastomeres of 8-cell Xenopus embryos were
cess SRF would be expected to diminish transcriptionalinjected with the indicated amount of mRNA encoding the C585
activation by myocardin through competition with SRFmutant of myocardin and 300 pg of GFP mRNA. Controls received
only GFP mRNA. At stage 28, embryos were stained for expression bound to DNA target sites, a phenomenon known as
of -cardiac actin, -tropomyosin, or Nkx2.5 by whole-mount in situ “squelching” (Ptashne, 1988). In support of this interpre-
hybridization, and the extent of heart formation on the injected side tation, previous studies have demonstrated that tran-
was determined.
scriptional activation by SRF is extremely sensitive to
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SRF levels and that high amounts of SRF can inhibit mary function appears to be as a transcriptional activator
because it contains a potent transcriptional activation do-activation by SRF, as well as other activators (Prywes
and Zhu, 1992). These findings have been interpreted main and it activates transfected CArG box-dependent
reporters that would not be expected to require complexto indicate that excess SRF titrates out a common co-
activator required for transcription. alterations in chromatin conformation for expression.
The behavior of SAP domain mutants of myocardinThe remarkable potency in which myocardin en-
hances SRF-dependent transcription raises interesting suggests that transcriptional activation of the SM22 and
ANF promoters may involve different mechanisms.questions about the specificity of target gene activation.
For example, different CArG box-dependent muscle Whereas the SAP domain was dispensible for SM22
activation, it was essential for ANF activation. Since thegenes exhibit different expression patterns; some are
specific for a particular type of muscle cell (e.g., cardiac, SAP domain is not required for association with SRF,
the ability of SAP domain mutants to discriminate be-skeletal, or smooth), and there is even specificity of
expression within subsets of muscle cells of a given tween the SM22 and ANF promoters suggests that this
domain may associate with other transcriptional regula-lineage. These unique expression patterns suggest that
additional factors, either positive or negative, are likely tors that differ between these two promoters.
to modulate the activity of myocardin and SRF.
Since growth-regulated genes controlled by CArG Potential Roles for Myocardin in Signal-
boxes are downregulated in post-mitotic differentiated Dependent Gene Expression Programs
muscle cells, there must be mechanisms that render In addition to the role of SRF in regulation of muscle
them nonresponsive to myocardin, just as there must be gene expression during development, SRF has also
mechanisms that prevent activation of SRF-dependent been implicated in reactivation of fetal cardiac genes in
muscle genes by growth signals. Such differential re- hypertrophic cardiomyocytes (Paradis et al., 1996). A
sponsiveness is likely to be dependent on the positions variety of calcium-dependent signaling pathways have
and numbers of CArG boxes within individual promoters been shown to stimulate SRF activity in response to
and the other factors that bind nearby sites. Many mus- hypertrophic stimuli. SRF activity is also enhanced in
cle-specific genes are regulated by pairs of CArG boxes response to changes in actin dynamics, which is likely
that act cooperatively (Chow and Schwartz, 1990; Lee to have important effects on muscle gene expression
et al., 1991; Mack and Owens, 1999), whereas many (Sotiropoulos et al., 1999). Whether such signals regu-
growth-regulated genes, such as c-fos, are controlled late the expression or activity of myocardin is an inter-
by single CArG boxes. Our findings demonstrate that esting issue for the future.
mutation of a single CArG box in the SM22 promoter
Experimental Proceduresresults in a greater than 100-fold reduction in respon-
siveness to myocardin. Thus, a requirement for multiple
Cloning and BioinformaticsCArG boxes to confer maximal sensitivity to myocardin
We screened for novel cardiac-specific genes in silico by performing
could contribute to muscle specificity. a BLAST search with ESTs from mouse embryonic heart cDNA librar-
SRF has also been shown to activate cardiac genes ies in the database. Two criteria were used to identify novel cardiac
in association with Nkx2.5 (Chen and Schwartz, 1996) genes: (1) sequences had to have been found only in cardiac cDNA
libraries, and (2) sequences had to be novel, without any knownand the zinc-finger protein GATA4 (Belaguli et al., 2000;
conserved domains. From this search, we identified 20 candidateMorin et al., 2001). However, there are several significant
cardiac-specific genes that were unknown. The correspondingdifferences between the effects of myocardin and these
cDNA fragments were cloned by polymerase chain reaction (PCR)
other factors on SRF-dependent transcription: (1) myo- and used as probes to perform whole-mount in situ hybridization
cardin potently activates transcription through the CArG on E9.5 mouse embryos. One of the cDNA sequences identified in
box, whereas Nkx2.5 and GATA factors do not activate this screen (accession number AI607474) corresponded to the 3
untranslated region of the myocardin transcript.CArG box transcription when expressed alone in trans-
fected cells. (2) Transcriptional activation by SRF with
In Situ Hybridization and Northern AnalysisNkx2.5 or GATA factors is relatively modest compared
Whole-mount and section in situ hybridization and Northern analy-to activation by myocardin and SRF. (3) SRF does not
ses were performed as described (Wang et al., 1999).
appear to form stable DNA binding ternary complexes
on the CArG box with Nkx2.5 or GATA4. Generation of Myocardin Mutants
Myocardin expression plasmids were generated through conven-
tional or PCR-based cloning. Site-directed mutagenesis was per-Regulation of Transcription and Chromosomal
formed using the QuickChange kit (Stratagene). For mutant Q,Organization by SAP Domain Proteins
cDNA sequences encoding amino acids 139–192 were removed.SAP domains have been identified in a variety of proteins
For mutantbasic, cDNA sequences encoding amino acids 115–134
involved in RNA processing and transcriptional control were removed.
(Aravind and Koonin, 2000). Recently, the SAP domain
of SAF-A was shown to mediate binding to SARs/MARs Transfection Assays
All myocardin expression vectors were cloned in pcDNA3.1 (In-(Kipp et al., 2000). These specialized AT-rich DNA se-
vitrogen), which was driven by the CMV promoter. A CMV-drivenquences, usually between 300 and 3000 bp long, are
human SRF eukaryotic expression vector (Chen and Schwartz, 1996)thought to partition the genome into topologically inde-
was used. The SM22-luciferase reporter contained the 1434 bp pro-pendent loops. Binding of the SAP domain of SAF-A to
moter and the CArG box mutations within it have been described
SARs has been proposed to create chromatin loops that (Li et al., 1997). The ANF-luciferase reporter contains the 638 bp
affect the expression of adjacent genes. While myocar- promoter (Sprenkle et al., 1995). The ANF CArG box mutations were
introduced by changing the consensus sequences as follows: CArG-din might have a role in chromatin remodeling, its pri-
Myocardin, a Transcriptional Cofactor for SRF
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far from CCATAAAAGG to CAATAAAAGC, and CArG-near from CCA associated positive and negative cis-acting promoter elements reg-
ulates transcription of the skeletal alpha-actin gene. Mol. Cell. Biol.AATATGG to CGAATTCTGG. The -MHC (Lu et al., 1999), MLC-2V
(Zhu et al., 1991), HRT2 (Nakagawa et al., 2000), dHAND (McFadden 10, 528–538.
et al., 2000), and Nkx2.5 (Lien et al., 1999) luciferase reporters have Cleaver, O.B., Patterson, K.D., and Krieg, P.A. (1996). Overexpres-
been described. sion of the tinman-related genes XNkx-2.5 and XNkx-2.3 in Xenopus
Transfections were performed with FuGENE6 (Roche) according embryos results in myocardial hyperplasia. Development 122, 3549–
to manufacturer’s instructions. Unless otherwise indicated, 100 ng 3556.
of reporter and 100 ng of each activator plasmid were used. The
Croissant, J.D., Kim, J.H., Eichele, G., Goering, I., Lough, J., Prywes,
total amount of DNA per well was kept constant by adding the
R., and Schwartz, R.J. (1996). Avian serum response factor expres-
corresponding amount of expression vector without a cDNA insert.
sion restricted primarily to muscle cell lineages is required for-actin
CMV-lacZ was used as an internal control to normalize for variations
gene transcription. Dev. Biol. 177, 250–264.
in transfection efficiency. All the proteins were expressed at a very
Fu, Y., Yan, W., Mohun, T.J., and Evans, S.M. (1998). Vertebratesimilar level as confirmed by Western blot.
tinman homologues XNkx2–3 and XNkx2–5 are required for heart
formation in a functionally redundant manner. Development 125,Immunostaining and Immunoprecipitation
4439–4449.Immunostaining and coimmunoprecipitation experiments were per-
Gille, H., Sharrocks, A.D., and Shaw, P.E. (1992). Phosphorylationformed as described previously (Lu et al., 1999).
of transcription factor p62TCF by MAP kinase stimulates ternary
complex formation at the c-fos promoter. Nature 358, 414–417.Gel Mobility Shift Assays
SRF and FLAG-tagged myocardin were translated in vitro with a TNT Gilman, M.Z., Wilson, R.N., and Weinberg, R.A. (1986). Multiple pro-
T7-coupled reticulocyte lysate system (Promega). The sequence of tein-binding sites in the 5-flanking region regulate c-fos expression.
the top strand oligonucleotide for SM22 CArG-far was: CTAGGTTT Mol. Cell. Biol. 6, 4305–4316.
CAGGGTCCTGCCATAAAAGGTTTTTCCCGGCCGCC. Gel mobility Grow, M.W., and Krieg, P.A. (1998). Tinman function is essential for
shift assays were performed as described (Chang et al., 2001). vertebrate heart development: elimination of cardiac differentiation
by dominant inhibitory mutants of the tinman-related genes,
Xenopus Injections and Analysis XNkx2–3 and XNkx2–5. Dev. Biol. 204, 187–196.
Xenopus laevis embryos were collected using standard techniques
Harland, R.M. (1991). In situ hybridization, an improved whole mountand were staged according to Nieuwkoop and Faber (1994). Syn-
method for Xenopus embryos. In Methods in Cell Biology, B.K. Kaythetic mRNAs encoding a truncated myocardin protein C585 were
and H.G. Peng, eds. (San Diego, CA: Academic Press), pp. 685–695.microinjected into the left dorsal-vegetal blastomere of 8-cell em-
Hauschka, S.D. (1994). The embryonic origin of muscle. In Myology,bryos using a variable automatic injector, as described (Cleaver et
2nd edition, A.G. Engel and C. Franzini-Armstrong, eds. (New York:al., 1996). Injected embryos were cultured at 18C in 3% Ficoll/100%
McGraw Hill, Inc.), pp.3–73.Steinberg’s buffer for 12 hr and then in 20% Steinberg’s buffer until
heart differentiation had occurred. In the standard protocol, between Hines, W.A., Thorburn, J., and Thorburn, A. (1999). A low-affinity
150 and 500 pg of myocardin mRNA was coinjected with 300 pg of serum response element allows other transcription factors to acti-
GFP mRNA. Injection results were assayed by whole-mount in situ vate inducible gene expression in cardiac myocytes. Mol. Cell. Biol.
hybridization (Harland, 1991), using Xenopus -tropomyosin, car- 19, 1841–1852.
diac -actin, or Nkx2.5 probes. Kim, S., Ip, H.S., Lu, M.M., Clendenin, C., and Parmacek, M.S. (1997).
A serum response factor-dependent transcriptional regulatory pro-
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